» Articles » PMID: 19135323

Guidelines for the Diagnosis and Management of Osteoporosis in Postmenopausal Women and Men from the Age of 50 Years in the UK

Overview
Journal Maturitas
Specialty Geriatrics
Date 2009 Jan 13
PMID 19135323
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

In 1999 and 2000 the Royal College of Physicians published guidelines for the prevention and treatment of osteoporosis [Royal College of Physicians. Osteoporosis: clinical guidelines for the prevention and treatment. London: Royal College of Physicians; 1999; Royal College of Physicians and Bone and Tooth Society of Great Britain. Update on pharmacological interventions and an algorithm for management. London, UK: Royal College of Physicians; 2000.; Royal College of Physicians. Glucocorticoid-induced osteoporosis. Guidelines on prevention and treatment; Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians. London, UK: Royal College of Physicians; 2002]. Since then, there have been significant advances in the field of osteoporosis including the development of new techniques for measuring bone mineral density, improved methods of assessing fracture risk and new treatments that have been shown to significantly reduce the risk of fractures. Against this background, the National Osteoporosis Guideline Group (NOGG), in collaboration with many Societies in the UK, have updated the original guidelines [Royal College of Physicians, National Osteoporosis Guideline Group on behalf of the Bone Research Society, British Geriatrics Society, British Orthopaedic Association, British Society of Rheumatology, National Osteoporosis Society, Osteoporosis 2000, Osteoporosis Dorset, Primary Care Rheumatology Society, Society for Endocrinology. Osteoporosis. Clinical guideline for prevention and treatment, Executive Summary. University of Sheffield Press; 2008], a practical summary of which is detailed below. The management algorithms are underpinned by a health economic analysis applied to the epidemiology of fracture in the UK.

Citing Articles

Expert consensus on vitamin D in osteoporosis.

Lei S, Zhang X, Song L, Wen J, Zhang Z, Tian J Ann Jt. 2025; 10:1.

PMID: 39981430 PMC: 11836767. DOI: 10.21037/aoj-24-48.


Persistently Elevated C-Reactive Protein Levels and Low Body Mass Index Are Associated with a Lack of Improvement in Bone Mineral Density in Crohn's Disease.

Koifman E, Krasnopolsky M, Ghersin I, Waterman M Nutrients. 2024; 16(17).

PMID: 39275145 PMC: 11396862. DOI: 10.3390/nu16172827.


Obesity and lipid metabolism in the development of osteoporosis (Review).

Wang X, Zhang C, Zhao G, Yang K, Tao L Int J Mol Med. 2024; 54(1).

PMID: 38818830 PMC: 11188977. DOI: 10.3892/ijmm.2024.5385.


The multi-faceted nature of age-associated osteoporosis.

Smit A, Meijer O, Winter E Bone Rep. 2024; 20:101750.

PMID: 38566930 PMC: 10985042. DOI: 10.1016/j.bonr.2024.101750.


Age-dependent FRAX-based assessment and intervention thresholds for therapeutic decision making in osteoporosis in the Malaysian population.

Ratnasingam J, Niyaz M, Mariyappan S, Ong T, Chan S, Hew F Arch Osteoporos. 2024; 19(1):18.

PMID: 38503995 DOI: 10.1007/s11657-024-01371-w.